BETA: Please send your feedback!
Scholastic
SCHL:NAS
Publishing: Books/Magazines
$1.16bn
SMALL cap
$33.40
(-0.90%)
-0.21%
since start of 2019
77.64
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 2
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 1998
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel medicines using its expertise in RNA biology. The company's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders and oncology. It is focused on developing treatments to fundamentally change the lives of patients living with rare genetic disorders. The company was founded by Allan S. Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
website
Headquarters
Executives
| Name | Title | Gender |
| Richard Robinson | Chairman, President & Chief Executive Officer | Male |
| Maureen E. O'Connell, CPA | CFO, Chief Administrative Officer & Executive VP | Female |
| Gil A. Dickoff | Treasurer, Senior VP & Head-Investor Relations | Male |
| Andrew S. Hedden | Secretary, Director, EVP & General Counsel | Male |
| Maurice R. Robinson | Founder | Male |
| Satbir Bedi | Chief Technology Officer | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 2
PTC Therapeutics - Competitors and Related Companies
How PTC Therapeutics stacks up to its peers in the Biotechnology industry or with competing business segments.
PTC Therapeutics
PTCT:NAS
Biotechnology
$2.57bn
SMALL cap
$43.68
(-1.49%)
0.27%
since start of 2019
-10.76
Loading…